Search
Search Results
##search.searchResults.foundPlural##
-
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277817PDF: 1849HTML: 3898 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4954PDF: 2924HTML: 2343 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4412PDF: 1427HTML: 2188 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2140PDF: 882HTML: 362 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2407PDF: 1025HTML: 2226 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3718PDF: 2597HTML: 1625 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7080PDF: 3761HTML: 814 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2995PDF: 1319HTML: 2834Figure 1: 199 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
207PDF: 198HTML: 16 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1091PDF: 742HTML: 276 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1661PDF: 1015HTML: 224 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2008PDF: 1148HTML: 1923Lung computed tomography CT scan image: 219 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6260PDF: 3435HTML: 9059Figure Malaria Ricci: 260 -
WHAT ARE FUNGAL INFECTIONS?
4324PDF: 2475HTML: 27699de Pauw: 263 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8227PDF: 4440HTML: 7559 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5776PDF: 1565HTML: 1663Untitled: 258 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1037PDF: 1274HTML: 127 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
1280PDF: 502HTML: 152 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3044PDF: 899HTML: 6612Untitled: 262Untitled: 218Untitled: 234Untitled: 249 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4321PDF: 1984HTML: 5517Table 1: 234 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
518PDF: 559Suppl. Files: 68HTML: 158 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3279PDF: 1146HTML: 1887 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2449PDF: 1911HTML: 172 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1772PDF: 827HTML: 878jdoe, table 2 infections CML .doc: 215jdoe, table 1 infections CML .doc: 202 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1161PDF: 913HTML: 291 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2782PDF: 1047HTML: 2392 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2692PDF: 1674HTML: 2451Table1: 212 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1308PDF: 546HTML: 23146







